GlassScriptPhysician profile
Michael David Kavanagh
NPI 1710513742
$27,605.57
in general payments reported to CMS, 2019-2025
12 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $829 · 2022: $570 · 2023: $462 · 2024: $1,356 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Food and Beverage: $2,271 · Travel and Lodging: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $23,333.33 |
| Food and Beverage | $2,270.55 |
| Travel and Lodging | $602.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $13,824.29 | 2025 | Acumed |
| Arthrex, INC. | $10,000.00 | 2025 | |
| Stryker Corporation | $2,148.04 | 2021-2025 | Mako, Gamma, Aequalis Perform Reversed |
| Medacta USA, INC. | $405.66 | 2022-2025 | Gmk Sphere |
| Skeletal Dynamics INC | $377.09 | 2021 | |
| Lightbody Medical Technologies INC | $233.82 | 2024-2025 | |
| Biocomposites INC | $181.45 | 2024 | |
| Depuy Synthes Sales INC. | $178.67 | 2021-2023 | Na |
| Si-Bone, INC. | $107.47 | 2022 | |
| Endo USA, INC. | $89.60 | 2025 | Xiaflex |
| Axogen | $43.48 | 2025 | |
| Zimmer Biomet Holdings, INC. | $16.00 | 2023 | Comprehensive Shoulder System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kavanagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.